Essential Hypertension. Therapeutic Trial of Veriloid, a New Extract of Veratrum viride. ∗

@article{Wilkins1949EssentialHT,
  title={Essential Hypertension. Therapeutic Trial of Veriloid, a New Extract of Veratrum viride. ∗},
  author={R. Wilkins and J. Stanton and E. Freis},
  journal={Proceedings of the Society for Experimental Biology and Medicine},
  year={1949},
  volume={72},
  pages={302 - 304}
}
Summary In hypertensive patients Veriloid is an active hypotensive agent when administered acutely, or chronically for periods as long as 5 months. Meticulous regulation of dosage is important in obtaining optimum results. After several weeks of continuous therapy it is frequently necessary to reduce the dosage in order to avoid nausea and vomiting. Nevertheless, relative to its hypotensive effects Veriloid seems to produce fewer toxic reactions than any other oral preparation of Veratrum… Expand
18 Citations
[Treatment of hypertension with oral protoveratrine].
A clinical evaluation of oral veriloid in the treatment of hypertensive disease.
The medical management of arterial hypertension.
  • E. Meilman
  • Medicine
  • The New England journal of medicine
  • 1953
...
1
2
...